Autophagy is the major intracellular pathway for the degradation and recycling of long-lived proteins and organelles and is thus crucial for cell homeostasis. It is induced by stress, over-crowding, or starvation conditions. C. elegans
bec-1 is the ortholog of beclin1/ATG6/VPS30 in mammals and yeast, an important regulator of autophagy. Yeast Atg6/Vps30p was identified in a genetic screen for mutants that are starvation sensitive or defective in vacuolar protein sorting. In mammals, beclin 1 has been shown to be a haploinsufficient tumor suppressor gene. Human Beclin 1 was identified as a protein interacting with the anti-apoptotic protein Bcl-2 in a yeast two-hybrid assay and is monoallelically deleted in up to 75% of various human cancers. Therefore, insights on the function of
bec-1 in C. elegans will likely shed light on its role in tumorigenesis in humans. We and others have found that
bec-1 functions in various biological processes, including survival, longevity, fat accumulation, dauer and reproductive development. In addition, we have recently shown that
bec-1 is important for the proper localization of MIG-14 to the Golgi network and is required for germ cell corpse clearance, implicating a role for
bec-1 in phagosome maturation. Thus,
bec-1 serves a role in both autophagy and endocytosis. Complete loss of
bec-1 results in lethality, therefore highlighting the importance of
bec-1 in development. Whereas many functions and interactions of Atg6/Beclin 1/BEC-1 have been described, little is known about the genes that regulate or act downstream of Atg6/Beclin 1/BEC-1 during development. A complete loss of function mutation of C. elegans
bec-1(
ok691) is essential for viability. We have isolated two dominant suppressor mutations that suppress the
bec-1 lethal phenotype, and named these mutants sub for suppressor of
bec-1 lethality. Importantly, both sub mutations suppress all
bec-1 loss of function phenotypes tested, including the decrease in fat accumulation in
bec-1 homozygous mutant animals, as well as the shortening of lifespan associated with heterozygous
bec-1 mutants. Using whole genome sequencing combined with SNP mapping, we have found various candidate mutations for
sub-1 and
sub-2. Since both mutations act dominantly in their suppression for
bec-1, they may represent either gain of function or haploinsufficient mutations. We will report on the molecular and genetic characterization of the sub mutations. We hypothesize that these suppressor mutations represent novel loci that may regulate
bec-1 mediated activity. Such novel loci would further our knowledge of BEC-1 and its role in development as well as provide new therapeutic targets for cancer treatment and age-related diseases.